Luciana Basili Dias CandidÃase vulvovaginal em pacientes gestantes
Luciana Basili Dias CandidÃase vulvovaginal em pacientes gestantes
Luciana Basili Dias CandidÃase vulvovaginal em pacientes gestantes
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Referências Bibliográficas 96<br />
Parewijck W, Claeys G, Thiery HVK. Candidiasis in women fitted an intrauterine contraceptive<br />
device. Br J Obstet Gynecol. 1988; 95: 408-10.<br />
Pathak A, Pien FD, Carvalho L. Amphotericin B use in a community hospital, with special<br />
<strong>em</strong>phasis on side effects. Clin. Infect. Dis. 1998; 26: 334-8.<br />
Perea S, Patterson TF. The roler of antifungal susceptibility testing in the manag<strong>em</strong>ent of<br />
patients with invasive mycoses. Rev. Iberoam. Micol. 1999; 16: 180-6.<br />
Peria MMF, Prevalência de fenótipos de resistência e espécies <strong>em</strong>ergentes de leveduras<br />
associadas a quadros de vulvovaginites. [dissertação]. São Paulo: Pesquisas Laboratoriais <strong>em</strong><br />
Saúde Pública; Infecções Fúngicas; Diagnóstico Micológico; 2003.<br />
Pray WS. Treatment of Vaginal Fungal Infections. U. S. Pharmacist. 2001; 26: 9.<br />
Pye GW, Marriot MS. Inhibition of terol C14 d<strong>em</strong>ethylation by imidazole-containing<br />
antifungals. Sabouraudia. 1982; 20: 325-9.<br />
Quindós G, Alonso-Vargas R, Helou S, Arechavala A, Mazuelos EG, Negroni R. Evaluación de<br />
um nuevo médio de cultivo cromógeno (Candida ID) para el aislamiento e idenficación<br />
presuntiva de Candida albicans y otras levaduras de interes médico. Rev. Iberoam Micol. 2001;<br />
18: 23-8.<br />
Reed BD. Risk factors for Candida vulvovaginitis. Obstet Gynecol Surv. 1992; 47: 551-60.<br />
Rex JH, Nelson PW, Paetznicj VL, Lozano-Chiu M, Espinel-Ingroff A, Anaissie EJ. Optimizing<br />
the correlation between results of testing in vitro for fluconazole by testing critical isolates in a<br />
murine model of invasive candidiasis. Antimicrob Agents Ch<strong>em</strong>other. 1998; 42: 129-34.<br />
Rex JH, Pfaller NA, Galgiani JN, Bartlett SM, Espinel-Ingroff A, Ghannoum MA, et al.<br />
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual<br />
framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and<br />
Candida infections. Clin. Infect. Dis. 1997; 24: 235-347.
Change language